Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to $798000.0.

  • Immunocore Holdings' Depreciation & Amortization (CF) fell 2289.86% to $798000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 1159.71%. This contributed to the annual value of $4.2 million for FY2024, which is 253.66% up from last year.
  • As of Q3 2025, Immunocore Holdings' Depreciation & Amortization (CF) stood at $798000.0, which was down 2289.86% from $780000.0 recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Depreciation & Amortization (CF) ranged from a high of $1.2 million in Q4 2024 and a low of $780000.0 during Q2 2025
  • For the 3-year period, Immunocore Holdings' Depreciation & Amortization (CF) averaged around $975090.9, with its median value being $1.0 million (2024).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 1298.45% in 2024, then tumbled by 2289.86% in 2025.
  • Immunocore Holdings' Depreciation & Amortization (CF) (Quarter) stood at $1.0 million in 2023, then increased by 12.98% to $1.2 million in 2024, then tumbled by 31.56% to $798000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $798000.0 for Q3 2025, versus $780000.0 for Q2 2025 and $854000.0 for Q1 2025.